Back to results
US 2025/0049801 A1Published application
Pharmaceutical combinations for use in the treatment of neoplastic diseases
AssigneeSillajen, Inc.
InventorsHeidi LANE, Felix BACHMANN, Karine LITHERLAND, Paul MCSHEEHY, Nicole FORSTER-GROSS
Life of this patent
Estimating the term…
Abstract
The present invention provides pharmaceutical combinations comprising (a) a TTK/PLK1 inhibitor (i.e. a compound of formula (I) or a pharmaceutically acceptable salt thereof as defend in the claims) and (b) a taxane anticancer drug or a pharmaceutically acceptable salt thereof (e.g. paclitaxel), as well as methods of using the combinations of the invention for the treatment of neoplastic diseases such as cancer.
Claims15
A pharmaceutical combination comprising
- (a) a compound of formula (I)
- or a pharmaceutically acceptable salt thereof;
- and
- (b) a taxane anticancer drug or a pharmaceutically acceptable salt thereof.
1 more element
(canceled)
(canceled)
Dependencies are inferred from the claim text.